Director

1100 New York Avenue NW, Suite 600
Washington, DC
20005

+12027728609

Patent star 2025

Spanish
French
German


Practice areas:

Patent litigation
Patent prosecution
Patent strategy & counseling

Industry sectors:

Biotechnology
Chemistry
Life sciences
Not-for-profit
Pharmaceutical


Jorge A. Goldstein, Ph.D. is a director in Sterne Kessler’s Biotechnology & Chemical Practice Group. Considered by his peers and clients to be one of the country’s pioneers in biotechnology patent law, in 2017, Jorge was inducted into LMG Life Sciences Hall of Fame and he was named as a finalist in their "Patent Strategy and Management Attorney of the Year - District of Columbia" category. He wrote the book “U.S. Biotechnology Patent Law” published in 2016, with a sixth edition including updates to case law published in 2021. The books guide readers to understanding case law dealing with patents in biotechnology. He has almost forty years’ experience in the preparation and prosecution of patent applications before the U.S. and foreign patent offices in scientific areas such as genomics, molecular and cell biology, recombinant DNA technology, immunology, transgenics, therapeutic methods, stem cells, pharmaceuticals and more recently, BioFETs (biological field effect transistors).

In addition, Jorge chairs the firm's IP and Human Rights Pro Bono Practice, which was recognized as the winner of the 2015 Financial Times' Most Innovative North American Lawyers award in the "Innovation in a Social Responsibility Project" category. He has handled multiple and varied interferences over many years, including successful appeals to the Court of Appeals for the Federal Circuit. He has also been involved in inter partes reviews at the USPTO, as well as European oppositions, and arbitrations in District Court and in Appellate litigation both as counsel and expert witness, and in counseling clients on intellectual property strategy, trade secrets, licensing, research contracts, university-industry relations, federal licensing, due diligence, acquisitions and employment agreements. He was lead counsel in the 1988 appellate case of In re Wands et al. 8 USPQ2d 1400 (Fed. Cir.), a pivotal decision on biotechnology enablement requirements.

Jorge received his J.D. from The George Washington University Law School with high honors, and his Ph.D. in chemistry from Harvard University. He earned his B.S. in chemistry from Rensselaer Polytechnic Institute.

Education/Alumni:
J.D., The George Washington University Law School, with high honors
Ph.D., Harvard University
B.S., Rensselaer Polytechnic Institute

 

Last updated November 2021